|
Search
Collections
Benchmarks
Upload document
Product
RSM01
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
1 indication
Indication
Respiratory Syncytial Virus Infection
Clinical trial
A Phase 1 Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of RSM01, a Monoclonal Antibody Targeting Respiratory Syncytial Virus, in Healthy Adults
Status: Completed
, Estimated PCD: 2022-08-23